Your browser doesn't support javascript.
loading
Tumor-Associated Raynaud's Phenomenon Exacerbated by Administration of Immune Checkpoint Inhibitors.
Sumi, Toshiyuki; Michimata, Haruhiko; Nagayama, Daiki; Koshino, Yuta; Watanabe, Hiroki; Yamada, Yuichi; Chiba, Hirofumi.
Afiliación
  • Sumi T; Department of Pulmonary Medicine, Hakodate Goryoukaku Hospital, Hokkaido, Japan; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan. Electronic address: tsh715@gmail.com.
  • Michimata H; Department of Pulmonary Medicine, Hakodate Goryoukaku Hospital, Hokkaido, Japan; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Nagayama D; Department of Pulmonary Medicine, Hakodate Goryoukaku Hospital, Hokkaido, Japan; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Koshino Y; Department of Pulmonary Medicine, Hakodate Goryoukaku Hospital, Hokkaido, Japan; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Watanabe H; Department of Pulmonary Medicine, Hakodate Goryoukaku Hospital, Hokkaido, Japan.
  • Yamada Y; Department of Pulmonary Medicine, Hakodate Goryoukaku Hospital, Hokkaido, Japan.
  • Chiba H; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan.
J Thorac Oncol ; 17(10): 1233-1234, 2022 10.
Article en En | MEDLINE | ID: mdl-36192079

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Raynaud / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Raynaud / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article